Eye on Innovation
policy and regulation
- FDA Approves First Generic Naloxone Nasal Spray
- Understanding the Marijuana Landscape
- Statement from FDA Commissioner Scott Gottlieb, M.D., on New Steps to Advance Agency’s Continued Evaluation of Potential Regulatory Pathways for Cannabis-Containing and Cannabis-Derived Products
- NIH-backed Startup Uses Machine Learning to Catch Opioid, Drug Theft
- NIH Starts Clinical Trial of Drug to Treat Cravings Associated with Opioid Use Disorder
- Opiant Eyes Q2 Launch for Pivotal Trial of Opioid Overdose Candidate Aimed at Fentanyl
- Mystery Opioid Overdose Device May Be a $1 Billion Opportunity
- FDA Rolls Out Vaping Policy to Make it Harder for Minors to Buy Flavored Products
- Opinion Letter by Luke Archibald and Alan Budney: What’s the Rush On Marijuana Legalization?